Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-22-000018

Chief Operating Officer sold 1,777 shares at an average $15.11 ($26,845)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Dowden Nathan J Chief Operating Officer 2022-09-08 Sale −912 $15.15 $13,814 69,613 D
Dowden Nathan J Chief Operating Officer 2022-09-09 Sale −865 $15.06 $13,031 68,748 D
Open-market sales · 1,777 sh · avg $15.11 · $26,845
Loading xslF345X03/wf-form4_166301365870769.xml…